These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26691725)

  • 1. Shared and divergent neurocognitive impairments in adult patients with schizophrenia and bipolar disorder: Whither the evidence?
    Kuswanto C; Chin R; Sum MY; Sengupta S; Fagiolini A; McIntyre RS; Vieta E; Sim K
    Neurosci Biobehav Rev; 2016 Feb; 61():66-89. PubMed ID: 26691725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder.
    Demmo C; Lagerberg TV; Aminoff SR; Hellvin T; Kvitland LR; Simonsen C; Andreassen OA; Melle I; Ueland T
    Bipolar Disord; 2016 Mar; 18(2):136-47. PubMed ID: 26990158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive Functioning in Schizophrenia and Bipolar Disorder: Clarifying Concepts of Diagnostic Dichotomy vs. Continuum.
    Kuswanto CN; Sum MY; Sim K
    Front Psychiatry; 2013; 4():162. PubMed ID: 24367337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia. A five-year follow-up.
    Jiménez-López E; Sánchez-Morla EM; López-Villarreal A; Aparicio AI; Martínez-Vizcaíno V; Vieta E; Rodriguez-Jimenez R; Santos JL
    Eur Psychiatry; 2019 Feb; 56():60-68. PubMed ID: 30500572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of childhood trauma on working memory in affective and non-affective psychotic disorders.
    Quidé Y; O'Reilly N; Rowland JE; Carr VJ; Elzinga BM; Green MJ
    Brain Imaging Behav; 2017 Jun; 11(3):722-735. PubMed ID: 27090803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Aparicio AI; Sánchez-Morla EM; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2017 Nov; 222():169-176. PubMed ID: 28709024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Sánchez-Morla EM; Aparicio AI; López-Villarreal A; Martínez-Vizcaíno V; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2018 Mar; 229():177-185. PubMed ID: 29316520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
    Chen CK; Lee CY; Lee Y; Hung CF; Huang YC; Lee SY; Huang MC; Chong MY; Chen YC; Wang LJ
    Psychiatry Res; 2018 Aug; 266():79-84. PubMed ID: 29852325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11.
    Carpenter WT; Bustillo JR; Thaker GK; van Os J; Krueger RF; Green MJ
    Psychol Med; 2009 Dec; 39(12):2025-42. PubMed ID: 19796428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross diagnostic comparisons of quality of life deficits in remitted and unremitted patients with schizophrenia and bipolar disorder.
    Sum MY; Ho NF; Sim K
    Schizophr Res; 2015 Oct; 168(1-2):191-6. PubMed ID: 26341581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain-processing abnormalities in bipolar I disorder, bipolar II disorder, and schizophrenia: A novel trait marker for psychosis proneness and functional outcome?
    Minichino A; Delle Chiaie R; Cruccu G; Piroso S; Di Stefano G; Francesconi M; Bersani FS; Biondi M; Truini A
    Bipolar Disord; 2016 Nov; 18(7):591-601. PubMed ID: 27782355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive function in euthymic bipolar disorder (BP I) patients with a history of psychotic symptoms vs. schizophrenia.
    Nenadic I; Langbein K; Dietzek M; Forberg A; Smesny S; Sauer H
    Psychiatry Res; 2015 Nov; 230(1):65-9. PubMed ID: 26319738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers?
    Bora E; Yucel M; Fornito A; Berk M; Pantelis C
    Acta Psychiatr Scand; 2008 Sep; 118(3):172-87. PubMed ID: 18699952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive burden of anticholinergic medications in psychotic disorders.
    Eum S; Hill SK; Rubin LH; Carnahan RM; Reilly JL; Ivleva EI; Keedy SK; Tamminga CA; Pearlson GD; Clementz BA; Gershon ES; Keshavan MS; Keefe RSE; Sweeney JA; Bishop JR
    Schizophr Res; 2017 Dec; 190():129-135. PubMed ID: 28390849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive Endophenotypes of Schizophrenia and Bipolar Disorder and Possible Associations with FKBP Variant rs3800373.
    Memic A; Streit F; Hasandedic L; Witt SH; Strohmaier J; Rietschel M; Oruc L
    Med Arch; 2018 Nov; 72(5):352-356. PubMed ID: 30524168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies.
    Seidman LJ; Giuliano AJ; Smith CW; Stone WS; Glatt SJ; Meyer E; Faraone SV; Tsuang MT; Cornblatt B
    Schizophr Bull; 2006 Jul; 32(3):507-24. PubMed ID: 16707777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.
    Reilly JL; Sweeney JA
    Schizophr Bull; 2014 May; 40(3):516-22. PubMed ID: 24574307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.